I take drops for dry eye which are very expensive. The drops were supposed to go off patent years ago. They are only on patent for a certain number of years. When they go off patent someone else can then make a generic which are usually much cheaper.
Bausch and Lomb who makes my eyedrops is a HUGE company. They had the market cornered. They pull sneaky legal manuvers which allow it to keep their eyedrop ON patent every time that the patent gets ready to run out. The customer then doesn't get a chance to get the generic or lower prices. They've been doing this for a long while.
My theory---I'm beginning to think that all these new OTC dry eye drops are from smaller eye companies that got tired of waiting for Bausch and Lomb's eyedrop to go off patent. These smaller companies have an eyedrop that does the same thing but are not allowed to sell it because of Bausch and Lomb's product patent. These smaller companies are just sitting there waiting, waiting and waiting with their thumbs up their butts for a chance to sell their product. I think these smaller companies took their eyedrop formula and watered it down until they were OTC strength and they are now selling their eyedrops that way. Just my theory.
Message Thread
« Back to index